NCT01155453View on ClinicalTrials.gov

A Study to Investigate Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of BKM120 Plus GSK1120212 in Selected Advanced Solid Tumor Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

113

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
Advanced and Selected Solid Tumors
Interventions
DRUG

BKM120

DRUG

GSK1120212

Trial Locations (7)

3000

Novartis Investigative Site, Leuven

6500

Novartis Investigative Site, Bellinzona

41013

Novartis Investigative Site, Seville

90095

University of California at Los Angeles Div. of Hematology/Oncology, Los Angeles

77030-4009

University of Texas/MD Anderson Cancer Center Dept of MD Anderson (8), Houston

M5G 2M9

Novartis Investigative Site, Toronto

08035

Novartis Investigative Site, Barcelona

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY